Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thromboplastin--sensitivity, precision and other characteristics.

K W Denson1

  • 1Thame Thrombosis and Haemostasis Research Foundation, Oxon.

Clinical and Laboratory Haematology
|January 1, 1988
PubMed
Summary

Higher concentrations of rabbit brain thromboplastin do not improve oral anticoagulant therapy results. Rabbit brain reagents lack the sensitivity of human brain thromboplastin, impacting International Normalized Ratio accuracy, especially at higher therapeutic ranges.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Passive smoking in infants, children and adolescents. The effects of diet and socioeconomic factors.

International archives of occupational and environmental health·2002
Same author

Rebuttal to: Passive smoking adversely affects the haemostasis/fibrinolytic parameters in healthy non-smoker offspring of healthy smokers.

Thrombosis and haemostasis·2001
Same author

Setting the tobacco record straight?

Lancet (London, England)·2000
Same author

Passive smoking and an increased risk of acute stroke.

Tobacco control·2000
Same author

Multicenter evaluation of lyophilized and deep-frozen plasmas for assignment of the International Normalized Ratio.

Thrombosis and haemostasis·1999
Same author

Passive smoking and coronary heart disease.

The New England journal of medicine·1999

Area of Science:

  • Biochemistry
  • Hematology
  • Clinical Chemistry

Background:

  • Oral anticoagulant therapy (OAT) monitoring relies on accurate prothrombin time (PT) testing.
  • Thromboplastin reagents, derived from rabbit or human brain, are used to standardize PT results.
  • Variability in thromboplastin sensitivity can affect therapeutic outcomes.

Purpose of the Study:

  • To evaluate the accuracy and precision of rabbit brain thromboplastin in OAT.
  • To compare the sensitivity of different thromboplastin reagents to coagulation factor VII.
  • To assess the suitability of rabbit brain thromboplastin for mimicking human brain thromboplastin's performance.

Main Methods:

  • Comparative analysis of thromboplastin reagents.
  • Assessment of reagent sensitivity to coagulation factor VII.

Related Experiment Videos

  • Evaluation of International Normalized Ratio (INR) performance in the upper therapeutic range.

    • Main Results:

    • Increased concentration or sensitivity of rabbit brain thromboplastin did not enhance accuracy or precision in OAT.
    • Rabbit brain thromboplastin failed to replicate the Prothrombinase-induced Vitamin K absence (PIVKA) sensitivity of human brain.
    • Certain reagents, including British Comparative Thromboplastin and Manchester Reagent, demonstrated poor factor VII sensitivity.

    Conclusions:

    • Rabbit brain thromboplastin is not a reliable substitute for human brain thromboplastin in OAT monitoring.
    • Inaccurate calibration of rabbit brain thromboplastin in higher therapeutic ranges can compromise patient safety.
    • Reagent selection is critical for achieving accurate and precise INR values in anticoagulant therapy.